Literature DB >> 12519762

Repression of farnesoid X receptor during the acute phase response.

Min Sun Kim1, Judy Shigenaga, Art Moser, Kenneth Feingold, Carl Grunfeld.   

Abstract

The acute phase response is associated with changes in the hepatic expression of genes involved in lipid metabolism. Nuclear hormone receptors that heterodimerize with retinoid X receptor (RXR), such as thyroid receptors, peroxisome proliferator-activated receptors, and liver X receptors, modulate lipid metabolism. We recently demonstrated that these nuclear hormone receptors are repressed during the acute phase response induced by lipopolysaccharide (LPS), consistent with the known decreases in genes that they regulate. In the present study, we show that LPS significantly decreases farnesoid X receptor (FXR) mRNA in mouse liver as early as 8 h after LPS administration, and this decrease was dose-dependent with the half-maximal effect observed at 0.5 microg/100 g of body weight. Gel-shift experiments demonstrated that DNA binding activity to an FXR response element (IR1) is significantly reduced by LPS treatment. Supershift experiments demonstrated that the shifted protein-DNA complex contains FXR and RXR. Furthermore, the expression of FXR target genes, SHP and apoCII, were significantly reduced by LPS (70 and 60%, respectively). Also, LPS decreases hepatic LRH expression in mouse, which may explain the reduced expression of CYP7A1 in the face of SHP repression. In Hep3B human hepatoma cells, both tumor necrosis factor (TNF) and interleukin-1 (IL-1) significantly decreased FXR mRNA, whereas IL-6 did not have any effect. TNF and IL-1 also decreased the DNA binding activity to an IR1 response element and the expression of SHP and apoCII. Importantly, TNF and IL-1 almost completely blocked the expression of luciferase activity linked to a FXR response element promoter construct transfected into Hep3B cells. Together with our earlier studies on the repression of RXRs, peroxisome proliferator-activated receptors, LXRs, thyroid receptors, constitutive androstane receptor, and pregnane X receptor, these results suggest that decreases in nuclear hormone receptors are major contributors to the decreased gene expression that occurs in the negative acute phase response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519762     DOI: 10.1074/jbc.M212633200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

2.  An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.

Authors:  Suriyan Ponnusamy; Quynh T Tran; Thirumagal Thiyagarajan; Duane D Miller; Dave Bridges; Ramesh Narayanan
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-16

3.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

4.  FXR regulates liver repair after CCl4-induced toxic injury.

Authors:  Zhipeng Meng; Yandong Wang; Lin Wang; Wen Jin; Nian Liu; Hao Pan; Lucy Liu; Lawrence Wagman; Barry M Forman; Wendong Huang
Journal:  Mol Endocrinol       Date:  2010-03-08

Review 5.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

6.  A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice.

Authors:  Weimin Guo; Dayong Wu; Maria C Dao; Lijun Li; Erin D Lewis; Edwin F Ortega; Heesun Eom; Michael Thomas; Mariana Nikolova-Karakashian; Mohsen Meydani; Simin N Meydani
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

7.  Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.

Authors:  Astrid Kosters; Damara D White; Hongdan Sun; Sundararajah Thevananther; Saul J Karpen
Journal:  J Hepatol       Date:  2009-08-20       Impact factor: 25.083

8.  Ligand-binding domain of farnesoid X receptor (FXR) had the highest sensitivity and activity among FXR variants in a fluorescence-based assay.

Authors:  Kyung-Hyun Cho; Ji-Young Park; Jang-Il Han; Tae-Sook Jeong
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

Review 9.  Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Authors:  Douglas G Burrin; Ken Ng; Barbara Stoll; Miguel Sáenz De Pipaón
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

Review 10.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.